DSG Capital Advisors LLC Buys Shares of 764 McKesson Co. (NYSE:MCK)

DSG Capital Advisors LLC acquired a new position in McKesson Co. (NYSE:MCK - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 764 shares of the company's stock, valued at approximately $435,000.

Other institutional investors have also recently bought and sold shares of the company. Capital A Wealth Management LLC purchased a new position in McKesson in the fourth quarter valued at about $26,000. Millstone Evans Group LLC purchased a new stake in McKesson in the 4th quarter worth about $28,000. Synergy Asset Management LLC purchased a new stake in McKesson in the 4th quarter worth about $32,000. Crews Bank & Trust bought a new stake in McKesson in the 4th quarter valued at about $33,000. Finally, Atala Financial Inc purchased a new stake in McKesson during the fourth quarter valued at about $34,000. Institutional investors own 85.07% of the company's stock.

Insider Buying and Selling

In other news, CAO Napoleon B. Rutledge, Jr. sold 543 shares of McKesson stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $726.51, for a total value of $394,494.93. Following the sale, the chief accounting officer now directly owns 1,972 shares of the company's stock, valued at approximately $1,432,677.72. The trade was a 21.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Britt J. Vitalone sold 1,878 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $717.91, for a total value of $1,348,234.98. Following the sale, the chief financial officer now directly owns 14,028 shares in the company, valued at $10,070,841.48. This trade represents a 11.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,856 shares of company stock valued at $7,793,675. 0.11% of the stock is owned by corporate insiders.

McKesson Stock Up 1.0%

Shares of NYSE MCK opened at $719.85 on Monday. The firm has a market capitalization of $90.06 billion, a P/E ratio of 32.96, a P/E/G ratio of 1.29 and a beta of 0.53. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $731.00. The stock's 50-day simple moving average is $695.18 and its two-hundred day simple moving average is $637.96.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $10.12 earnings per share for the quarter, beating the consensus estimate of $9.83 by $0.29. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The firm had revenue of $90.82 billion for the quarter, compared to analysts' expectations of $94 billion. During the same period in the prior year, the firm earned $6.18 EPS. The company's revenue was up 18.9% compared to the same quarter last year. As a group, research analysts anticipate that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be paid a dividend of $0.71 per share. The ex-dividend date of this dividend is Monday, June 2nd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.39%. McKesson's dividend payout ratio (DPR) is presently 10.99%.

Wall Street Analysts Forecast Growth

MCK has been the subject of several recent research reports. Mizuho lifted their target price on shares of McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a research note on Thursday, April 3rd. Bank of America raised their price objective on shares of McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a report on Friday, May 9th. Wall Street Zen raised shares of McKesson from a "buy" rating to a "strong-buy" rating in a report on Friday. UBS Group increased their target price on McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a research report on Tuesday, April 29th. Finally, Evercore ISI lifted their price target on McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a research report on Thursday, February 6th. Three analysts have rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, McKesson presently has a consensus rating of "Moderate Buy" and a consensus target price of $686.69.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.